These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33860835)

  • 1. Screening of compound library identifies novel inhibitors against the MurA enzyme of Escherichia coli.
    Raina D; Tiwari H; Sharma S; Deepika ; Chinthakindi PK; Nargotra A; Sangwan PL; Eniyan K; Bajpai U; Vishwakarma RA; Khan FG; Saran S; Khan IA
    Appl Microbiol Biotechnol; 2021 May; 105(9):3611-3623. PubMed ID: 33860835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boswellic acids, as novel inhibitor targeting peptidoglycan biosynthetic enzyme UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) in Escherichia coli.
    Raina D; Khan FG; Tiwari H; Sangwan PL; Nargotra A; Kumar V; Khan IA; Saran S
    Arch Microbiol; 2022 Jul; 204(8):472. PubMed ID: 35819545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of New Inhibitors of UDP-N-Acetylglucosamine Enolpyruvyl Transferase (MurA) by Virtual Screening with Antibacterial Assessment.
    Boulhissa I; Chikhi A; Bensegueni A; Ghattas MA; Mokrani EH; Alrawashdeh S; Obaid DEE
    Curr Comput Aided Drug Des; 2021; 17(2):214-224. PubMed ID: 32053077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covalent inhibitors of bacterial peptidoglycan biosynthesis enzyme MurA with chloroacetamide warhead.
    Grabrijan K; Hrast M; Proj M; Dolšak A; Zdovc I; Imre T; Petri L; Ábrányi-Balogh P; Keserű GM; Gobec S
    Eur J Med Chem; 2022 Dec; 243():114752. PubMed ID: 36126388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel MurA inhibitors using
    Tiwari H; Raina D; Gupta M; Barik MR; Khan IA; Khan F; Nargotra A
    J Biomol Struct Dyn; 2023 Feb; 41(2):457-468. PubMed ID: 34866550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo functional activity of Chlamydia MurA, a UDP-N-acetylglucosamine enolpyruvyl transferase involved in peptidoglycan synthesis and fosfomycin resistance.
    McCoy AJ; Sandlin RC; Maurelli AT
    J Bacteriol; 2003 Feb; 185(4):1218-28. PubMed ID: 12562791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) from Vibrio fischeri that confers high fosfomycin resistance in Escherichia coli.
    Kumar S; Parvathi A; Hernandez RL; Cadle KM; Varela MF
    Arch Microbiol; 2009 May; 191(5):425-9. PubMed ID: 19277606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of 1,2-diaryl-3-oxopyrazolidin-4-carboxamides as a new class of MurA enzyme inhibitors and characterization of their antibacterial activity.
    Wagdy RA; Abutaleb NS; Fathalla RK; Elgammal Y; Weck S; Pal R; Fischer PD; Ducho C; Abadi AH; N Seleem M; Engel M; Abdel-Halim M
    Eur J Med Chem; 2023 Dec; 261():115789. PubMed ID: 37717380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docking of T6361 Analogues as Potential Inhibitors of
    Boulhissa I; Boucherit H; Chikhi A; Bensegueni A
    Curr Drug Discov Technol; 2024; 21(3):1-8. PubMed ID: 37929742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of UDP-N-acetylglucosamine enolpyruvyl transferase, an enzyme essential for the synthesis of bacterial peptidoglycan, complexed with substrate UDP-N-acetylglucosamine and the drug fosfomycin.
    Skarzynski T; Mistry A; Wonacott A; Hutchinson SE; Kelly VA; Duncan K
    Structure; 1996 Dec; 4(12):1465-74. PubMed ID: 8994972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of new MurA inhibitors using induced-fit simulation and docking.
    Rožman K; Lešnik S; Brus B; Hrast M; Sova M; Patin D; Barreteau H; Konc J; Janežič D; Gobec S
    Bioorg Med Chem Lett; 2017 Feb; 27(4):944-949. PubMed ID: 28077258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA-encoded library screening on two validated enzymes of the peptidoglycan biosynthetic pathway.
    Proj M; Bozovičar K; Hrast M; Frlan R; Gobec S
    Bioorg Med Chem Lett; 2022 Oct; 73():128915. PubMed ID: 35917835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Allylpyrocatechol Derivatives as Antibacterial Agent Against Oral Pathogen of
    Kurnia D; Hutabarat GS; Windaryanti D; Herlina T; Herdiyati Y; Satari MH
    Drug Des Devel Ther; 2020; 14():2977-2985. PubMed ID: 32801638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzothioxalone derivatives as novel inhibitors of UDP-N-acetylglucosamine enolpyruvyl transferases (MurA and MurZ).
    Miller K; Dunsmore CJ; Leeds JA; Patching SG; Sachdeva M; Blake KL; Stubbings WJ; Simmons KJ; Henderson PJ; De Los Angeles J; Fishwick CW; Chopra I
    J Antimicrob Chemother; 2010 Dec; 65(12):2566-73. PubMed ID: 20861142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and structure-activity relationship study of novel quinazolinone-based inhibitors of MurA.
    Hrast M; Rožman K; Jukič M; Patin D; Gobec S; Sova M
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3529-3533. PubMed ID: 28579123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of peptidomimetic compounds as potential inhibitors against MurA enzyme of
    Kumar P; Saumya KU; Giri R
    J Biomol Struct Dyn; 2020 Oct; 38(17):4997-5013. PubMed ID: 31755364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of new inhibitors of the Escherichia coli MurA enzyme.
    Baum EZ; Montenegro DA; Licata L; Turchi I; Webb GC; Foleno BD; Bush K
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3182-8. PubMed ID: 11600375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UDP-N-acetylglucosamine enolpyruvyl transferase as a potential target for antibacterial chemotherapy: recent developments.
    Gautam A; Rishi P; Tewari R
    Appl Microbiol Biotechnol; 2011 Oct; 92(2):211-25. PubMed ID: 21822642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nature of Staphylococcus aureus MurA and MurZ and approaches for detection of peptidoglycan biosynthesis inhibitors.
    Blake KL; O'Neill AJ; Mengin-Lecreulx D; Henderson PJ; Bostock JM; Dunsmore CJ; Simmons KJ; Fishwick CW; Leeds JA; Chopra I
    Mol Microbiol; 2009 Apr; 72(2):335-43. PubMed ID: 19298367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that the fosfomycin target Cys115 in UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) is essential for product release.
    Eschenburg S; Priestman M; Schönbrunn E
    J Biol Chem; 2005 Feb; 280(5):3757-63. PubMed ID: 15531591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.